MHRA September 2018

The big news that related to general practice was about EpiPen.

All healthcare professionals should be aware of the recent supply disruption alert from the Department of Health & Social Care (DHSC) on management of the supply disruption of EpiPen and EpiPen Junior. MHRA has allowed an extension of use beyond the expiry date for certain batches of EpiPen 300 microgram adrenaline autoinjectors.

Patients can continue to use CERTAIN BATCHES OF the EpiPen 300 microgram auto-injectors of specified lots safely until the extended use-by date in the table. Further information about batches affected can be found within the alert and on the EpiPen website.

 

Comments are closed.